A STTR Phase I contract was awarded to Sorrento Therapeutics in July, 2014 for $586,535.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase II contract was awarded to Sorrento Therapeutics in July, 2014 for $1,997,627.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Sorrento Therapeutics for $224,550.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Sorrento Therapeutics for $600,000.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Sorrento Therapeutics for $598,689.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Sorrento Therapeutics for $597,832.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Sorrento Therapeutics for $224,823.0 USD from the U.S. Department of Health & Human Services.